International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populationsDan H. Barouch, Jaap Goudsmit, Lori F. Maxfield et al.|Vaccine|2011Cited by 308
First-in-Human Randomized, Controlled Trial of Mosaic HIV-1 Immunogens Delivered via a Modified Vaccinia Ankara VectorLindsey R. Baden, Kelly Stanley, Stephen R. Walsh et al.|The Journal of Infectious Diseases|2018Cited by 45
Timing of Plasmid Cytokine (IL-2/Ig) Administration Affects HIV-1 Vaccine Immunogenicity in HIV-Seronegative SubjectsLindsey R. Baden, William A. Blattner, Cecilia Morgan et al.|The Journal of Infectious Diseases|2011Cited by 25